Evidence map›Paper›PMID 26929332›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Structural basis for DNA cleavage by the potent antiproliferative agent (-)-lomaiviticin A.

Christina M Woo, Zhenwu Li, Eric K Paulson, Seth B Herzon

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Structure Revision of the Lomaiviticins.Journal of the American Chemical Society · 2021
    Article
  5. Synthesis and Biological Evaluation of (2Journal of the American Chemical Society · 2021
    Article
  6. Structure and bioactivity of colibactin.Bioorganic & medicinal chemistry letters · 2020
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. The Mechanism of Action of (-)-Lomaiviticin A.Accounts of chemical research · 2017
    Article
  15. Review
  16. Review
  17. Mechanism of Nucleophilic Activation of (-)-Lomaiviticin A.Journal of the American Chemical Society · 2016
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Christina M WooDepartment of Chemistry, Yale University, New Haven, CT 06520;
Zhenwu LiDepartment of Chemistry, Yale University, New Haven, CT 06520;
Eric K PaulsonDepartment of Chemistry, Yale University, New Haven, CT 06520;ORCID http://orcid.org/0000-0002-4612-3634
Seth B HerzonDepartment of Chemistry, Yale University, New Haven, CT 06520; Department of Pharmacology, Yale School of Medicine, New Haven, CT 06520 seth.herzon@yale.edu.
Yale University · US

Funding

Synthetic, Chemical Biological, and Preclinical Studies of Antitumor Natural Products and Their DerivativesR01GM090000 · NIGMS · YALE UNIVERSITY · PI HERZON, SETH B. · 2011 to 2018
$2.4M
NIGMS NIH HHS R01 GM090000NIGMS NIH HHS R01GM090000
6 · The paper itself

Abstract

(-)-Lomaiviticin A (1) is a complex antiproliferative metabolite that inhibits the growth of many cultured cancer cell lines at low nanomolar-picomolar concentrations. (-)-Lomaiviticin A (1) possesses a C2-symmetric structure that contains two unusual diazotetrahydrobenzo[b]fluorene (diazofluorene) functional groups. Nucleophilic activation of each diazofluorene within 1 produces vinyl radical intermediates that affect hydrogen atom abstraction from DNA, leading to the formation of DNA double-strand breaks (DSBs). Certain DNA DSB repair-deficient cell lines are sensitized toward 1, and 1 is under evaluation in preclinical models of these tumor types. However, the mode of binding of 1 to DNA had not been determined. Here we elucidate the structure of a 1:1 complex between 1 and the duplex d(GCTATAGC)2 by NMR spectroscopy and computational modeling. Unexpectedly, we show that both diazofluorene residues of 1 penetrate the duplex. This binding disrupts base pairing leading to ejection of the central AT bases, while placing the proreactive centers of 1 in close proximity to each strand. DNA binding may also enhance the reactivity of 1 toward nucleophilic activation through steric compression and conformational restriction (an example of shape-dependent catalysis). This study provides a structural basis for the DNA cleavage activity of 1, will guide the design of synthetic DNA-activated DNA cleavage agents, and underscores the utility of natural products to reveal novel modes of small molecule-DNA association.

Indexed as

DNA CleavageAngucyclines and AngucyclinonesAntibiotics, AntineoplasticDNAFluorenesFluorescenceMagnetic Resonance SpectroscopyMicrococcusModels, MolecularNucleic Acid ConformationNucleic Acid HeteroduplexesAngucyclines and AngucyclinonesAntibiotics, Antineoplasticcalf thymus DNADNAFluoreneslomaiviticin ANucleic Acid HeteroduplexesDNAdouble-strand breaknatural productNMR

Identifiers

PMID26929332
PMCPMC4801295
OpenAlexW2288418910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.